# 06-10 TICK-BORNE DISEASES

![](https://i.imgur.com/wwPlQUZ.jpg)

–: <15%, +: 15–25%, ++: 25–50%, +++: 50–75%, ++++: >75%

LYME DISEASE

Microbiology

• **Spirochete** _B. burgdorferi_ (consider coinfection with _Anaplasma, Babesia, B. miyamotoi_)

• Transmitted by **ticks** (_Ixodes_, deer tick); infxn usually requires **tick attached** >**36–48 h**

流行病學

• Most common vector-borne illness in U.S.; peak incidence in summer (May–Aug)

• Majority of cases in MN, WI, New England, northern mid-Atlantic, northern CA

• Humans contact ticks usually in fields with low brush near wooded areas

<table><colgroup><col> <col></colgroup><tbody><tr><td colspan="2"><p><b>臨床表現</b></p></td></tr><tr><td><p><b>Stage</b></p></td><td><p><b>表現</b></p></td></tr><tr><td><p><b>Stage 1 (early localized)</b> 3–30 d after bite</p></td><td><p>Pathogenesis: local effects of spirochete. <i>General:</i> <b>flu-like illness</b></p><p><i>Derm</i> (~80%): <b>erythema migrans</b> (EM) = erythematous patches with central clearing, ~6–38 cm in size &amp; often not “annular”</p></td></tr><tr><td><p><b>Stage 2 (early dissem.)</b> wks to mos after bite</p></td><td><p>Pathogenesis: spirochetemia and immune response</p><p><i>General:</i> fatigue, malaise, LAN, HA; fever uncommon</p><p><i>Derm:</i> <b>multiple (1–100) annular lesions ≈ EM</b></p><p><i>Rheum</i> (~10%): <b>migratory arthralgias</b> (knee &amp; hip) <b>&amp; myalgias</b></p><p><i>Neurologic</i> (~15%): cranial neuropathies (esp. <b>CN VII</b>), aseptic meningitis, mononeuritis multiplex (± pain), transverse myelitis</p><p><i>Cardiac</i> (~8%): <b>conduction block</b>, myopericarditis</p></td></tr><tr><td><p><b>Stage 3 (late persistent)</b> mos to yrs after bite</p></td><td><p>Pathogenesis: immune response</p><p><i>Derm</i> (rare in U.S.)<i>:</i> acrodermatitis chronica atrophicans, panniculitis</p><p><i>Rheum</i> (~60%, espec. if not Rx’d): <b>recurrent mono- or oligoarthritis of large joints</b> (classically knee), synovitis</p><p><i>Neurologic</i> (rare!)<i>:</i> subacute encephalomyelitis, polyneuropathy</p></td></tr></tbody></table>

(_CID_ 2006;43:1089; _Lancet_ 2012;379:461; _NEJM_ 2014;370:1724)

Diagnostic studies

• _EM present:_ confirmed in appropriate geographic setting; no need for testing (likely sero ⊖)

• _EM absent_ (ie, stage 2 or 3 disease): 2-step testing

1st step: ELISA screen (false ⊕ common, false ⊖ with early 抗生素 or <6 wk after tick bite)

2nd step: if ⊕ ELISA, confirm with Western blot (↑ Sp)

• ✔ CSF if suspected neuro disease: ⊕ CSF Ab if (IgGCSF/IgGserum)/(albCSF/albserum) >1

治療 (_NEJM_ 2014;370:1724; _JAMA_ 2016;315:1767 & 2461)

• **Prophylaxis:** tick avoidance, protective clothing, tick ✔ q24h, DEET

Chemoprophylaxis with doxycycline 200 mg PO × 1 _only_ if _all_ of the following:

1\. _Ixodes scapularis_ tick attached ≥36 h

2\. Local Lyme carriage in ticks ≥20% (peak season in endemic area)

3\. 抗生素 can be given within ≤72 h of tick bite

4\. No contraindication to doxy (eg, preg, allergy, age <8 y)

If criteria 1–4 met, NNT to prevent 1 case ~50; without doxy, risk of Lyme after tick bite 1–3%

Regardless of Ppx, monitor for fever, flu-like sx, rash (erythema migrans) × 30 d

• **抗生素** (ISDA 2019): _if_ clin. manifest. _and_ ⊕ serology in endemic area (unless isol. EM)

Isolated EM: **doxy** 100 mg PO bid × 10 d (altern: cefurox or amox × 14 d or azithro × 7 d)

_Arthritis:_ **doxy** 100 mg PO bid × 28 d (alternative: cefurox or amox × 28 d)

_Carditis or meningitis:_ **CTX** 2 g IV q24h or doxy 100 mg PO bid (IV vs. PO depends on severity, 臨床improvement) × 2–3 wk

• Consider coinfection if severe/refractory sx, persistent fever, cytopenias

BABESIOSIS

Microbiology & 流行病學

• Infxn with parasite _Babesia microti_ (U.S.), transmitted by _Ixodes_ ticks; also a/w transfusion

• Europe & U.S. (more commonly MN, WI, **coastal areas & islands of MA**, NY, NJ, RI, CT)

• Peak incidence June–August (_MMWR_ 2012;61:505)

臨床表現 (typically 1–4 wk after tick exposure; <9 wk if transfusion)

• Range from asx to fevers, sweats, myalgias, & HA to severe hemolytic anemia, hemoglobinuria, & death (degree of parasitemia correlates roughly with severity)

• Risk factors for severe disease: **asplenia**, ↓ cellular immunity, TNF inhib, ↑ age, pregnancy

Diagnosis (_NEJM_ 2012;366:2397)

• 臨床syndrome **\+ blood smear with intraerythrocytic parasites**

• Repeat smears (q12–24h) if sx persist despite negative initial smear

• PCR serum if smear ⊖ and high 臨床suspicion, serum IgG can help but some false ⊕

治療 (_JAMA_ 2016;315:1767)

• Atovaquone & azithro for mild/mod illness; **call ID if severe** (azithro/atovaquone/clinda)

• Duration depends on host; immunosupp 病人 often need longer Rx

• Exchange transfusion if parasitemia >10%, severe hemolysis or SIRS

EHRLICHIOSIS/ANAPLASMOSIS

Microbiology

• Gram ⊖ obligate intracellular bacterium; **human monocytic ehrlichiosis** (_E. chaffeensis_, HME); **human granulocytic anaplasmosis** (_A. phagocytophilum_, HGA)

• Transmission: HME by _Amblyomma americanum_, _Dermacentor variabilis;_ HGA by _Ixodes_

流行病學

• **HGA** cases typically in New Engl, mid-Atl, MN; **HME** in SE and south-central U.S.

• Peak incidence spring and early summer; can be transmitted by blood transfusion

臨床表現 (typically within 3 wk of tick exposure)

• Asx or nonspecific: fever, myalgias, malaise, HA, cough, dyspnea; onset often acute

• Laboratory: leukopenia, thrombocytopenia, ↑ aminotransferases, LDH, Aφ, renal insuff

• More severe disease can occur with bacterial superinfection in HGA

Diagnosis

• Acute: intraleukocytic morulae on peripheral blood smear (rare); **PCR;** later: serology

治療 (_JAMA_ 2016;315:1767)

• Start Rx based on 臨床suspicion; definitive dx requires PCR (may not detect all spp.)

• Doxycycline 100 mg PO bid (often × 10 d); should defervesce in ≤48 h, else reconsider dx

ROCKY MOUNTAIN SPOTTED FEVER (RMSF)

Microbiology & 流行病學

• Infection with _Rickettsia rickettsii_ (Gram ⊖ obligate intracellular bacterium)

• Transmitted by _Dermacentor variabilis, D. andersoni_ (dog tick); peak in spring/early summer

• Occurs in **mid-Atl, SE, Midwest**, New Engl, NW, Canada, Mexico, Central & S. America

• Consider other rickettsial spp.: _R. akari_ (Rickettsial pox), _R. conorii_ (Mediterranean spotted fever), _R. africae_ (African tick bite fever), _R. felis_ (Flea rickettsiosis)

臨床表現 (typically within 1 wk of tick exposure)

• Nonspecific: **fever**, **HA**, ΔMS, myalgias, N/V, occasionally abdominal pain

• **Rash** (2–5 d _after_ onset) = _centripetal:_ starts on ankles and wrists → trunk, palms, & soles; progresses from macular to maculopapular to petechial

• Severe cases → vasculitis, hypoperfusion/shock, end-organ damage; more likely in elderly

• Up to 75% mortality if untreated, 5–10% even with Rx (esp. if delayed) (_NEJM_ 2005;353:551)

Diagnosis

• Usually a 臨床dx; _requires early 臨床suspicion_ given risks of delayed Rx

• Acute illness dx by **skin bx** for rickettsiae (Se ~70%); 7–10 d after sx onset, serology ⊕

治療

• Doxycycline 100 mg PO bid _(give empirically if 臨床suspicion)_

TULAREMIA

Microbiology

• Infxn with _Francisella tularensis_ via contact with animal tissue, aerosol, tick/insect bite

臨床表現 (typically within 2–10 d of exposure)

• Acute onset of fever, HA, nausea; ulcer with black eschar at site of entry; LAN; PNA

Diagnosis & 治療

• Hazardous and difficult to Cx, alert lab. Serology ⊕ by wk 2. PCR by research lab.

• Streptomycin or gentamicin × 7–14 d; empiric Rx may be needed given challenges in dx
